TL;DR
Researchers have identified a new optical phenomenon observed during slit-lamp examinations in keratoconus patients, termed the "Halo Sign." This sign, characterized by an annular light reflex on the iris, appears to be more prevalent in advanced stages of the disease and can be quantified using a novel "Halo Morphology Index" (HMI) to describe its shape and irregularity.
What Problem Does This Paper Address?
Keratoconus (KC) is a progressive eye condition that causes the cornea to thin and bulge into a cone shape, leading to significant vision impairment. Diagnosing and staging KC often relies on specialized and expensive equipment like corneal topography and biomechanical assessments. In resource-limited settings, clinicians depend more on observable slit-lamp signs. While some classic signs exist (e.g., Vogt's striae), there's a need for new, easily observable optical signs that can aid in early detection and severity assessment. This paper addresses the need to characterize a recently identified slit-lamp phenomenon, the "Halo Sign," and explore its relationship with the clinical and tomographic severity of keratoconus.
Methods
This study employed a retrospective, observational case series design. The researchers examined 22 eyes from 11 patients diagnosed with keratoconus. A key methodological innovation was the development of the "Halo Morphology Index" (HMI). This index quantifies the shape of the Halo Sign by calculating the aspect ratio (major axis / minor axis) of an ellipse fitted to the outline of the halo observed on slit-lamp photographs, measured using ImageJ software. Standard clinical data, including corrected distance visual acuity (CDVA), Amsler-Krumeich (AK) staging, thinnest corneal thickness (Thk), keratometric indices, and higher-order aberrations (HOAs), were collected. Additionally, Anterior Segment Optical Coherence Tomography (AS-OCT) was used for structural staging.
Datasets
The study utilized data from 22 eyes of 11 consecutive keratoconus patients treated at a single tertiary center. No new benchmark datasets were introduced; the focus was on analyzing existing clinical and imaging data from these patients.
Key Insights and Ideas
- A New Clinical Sign: The "Halo Sign" is a novel, observable optical phenomenon that can be detected during routine slit-lamp examinations.
- Indicator of Severity: The presence and morphology of the Halo Sign appear to correlate with the severity of keratoconus, being predominantly observed in advanced stages (AK stage IV).
- Quantitative Measurement: The HMI provides a standardized, image-based method to quantify the irregularity of the halo, offering a more objective measure than simple visual assessment.
- Complementary to Existing Tools: While not a standalone diagnostic tool, the Halo Sign and its HMI could serve as a valuable supplementary observation, especially in settings lacking advanced imaging equipment, prompting further evaluation.
- Potential for Understanding Pathophysiology: The study suggests that the Halo Sign is not merely an incidental artifact but may be linked to the structural and optical changes occurring in the keratoconic cornea, potentially related to caustics, thin-film interference, or light scattering.
Key Results
- The Halo Sign was present in 8 out of 22 eyes (Group B) and absent in 14 eyes (Group A).
- All Halo-positive eyes (Group B) were classified as AK stage IV, while Halo-negative eyes (Group A) spanned AK stages I-IV.
- Halo-positive eyes generally exhibited worse CDVA, thinner corneas, steeper keratometry, and a higher prevalence of corneal scarring compared to Halo-negative eyes.
- Cone decentration (KVD) was also greater in Halo-positive eyes.
- AS-OCT staging showed Halo-positive eyes were more frequently classified as OCT stage 2, while Halo-negative eyes were mostly OCT stage 1.
- HMI values in Halo-positive eyes ranged from 1.07 to 3.93, indicating a spectrum from near-circular to highly irregular halo outlines. Higher HMI values correlated with more advanced disease and greater corneal irregularity.
Limitations and Future Work
The authors acknowledge several limitations:
- Small Sample Size: The study included only 11 patients (22 eyes), which limits the generalizability of the findings and statistical power.
- Cross-Sectional Design: The study could not assess the utility of the Halo Sign in monitoring disease progression over time.
- HMI Limitations: The HMI quantifies outline anisotropy but does not directly measure ring completeness (e.g., continuity or gap size).
Future work should focus on:
- Larger Prospective Studies: Conducting larger studies with standardized imaging protocols and prespecified analyses to validate these findings.
- Longitudinal Monitoring: Investigating how HMI changes over time and whether it tracks keratoconus progression within individual eyes.
- Exploring Complementary Descriptors: Evaluating other shape descriptors (e.g., circularity, solidity) to provide a more comprehensive characterization of the halo.
- Investigating Pathophysiology: Further research is needed to elucidate the precise mechanisms underlying the formation and variation of the Halo Sign.
Summary updated